居家老年共病患者多重用药现况调查及其影响因素分析  

Investigation of polypharmacy in domiciliary multimorbidity elderly and analysis of influencing factors

作　　者：沈晨 侯惠如[2] 杨庭树[3] 孟文文[4] Shen Chen;Hou Huiru;Yang Tingshu(Medical School PLA,Beijing 100853,China)

机构地区：[1]解放军医学院,北京100853 [2]解放军总医院第二医学中心护理部 [3]解放军总医院心血管医学部 [4]解放军总医院京北医疗综合外科

出　　处：《中华保健医学杂志》2021年第6期586-588,共3页Chinese Journal of Health Care and Medicine

基　　金：国家重点研发计划(2018YFC2002400)。

摘　　要：目的探究居家老年共病患者多重用药现状及其影响因素。方法自行设计问卷,抽选2020年8月~11月期间在北京市某三甲医院门诊参加体检年龄≥60周岁的219名患有共病的老年人作为研究对象,调查居家的老年共病患者多重用药现况。结果调查发现,155例患者存在多重用药情况,多重用药率达到了70.8%。该调查人群,每日平均服用药物(8.6±3.2)种,服用药物的数量最少为5片(粒/丸),最多为72.5片(粒/丸),用药不良反应发生率则达到29%。年龄、疾病种类、用药依从性是居家老年共病患者多重用药的影响因素。结论居家老年共病患者是发生多重用药的高危人群,针对影响因素管理居家老年共病患者多重用药,对患者的用药安全具有重要意义。Objective To investigate the status and influencing factors of polypharmacy in domiciliary multimorbidity elderly.Methods Design the questionnaire,a total of 219 elderly patients aged≥60 years old with multimorbidity who underwent physical examination in the outpatient department of a third grade A hospital in Beijing from August to November 2020 were selected as the research subjects.Results The survey found,155 elderly multimorbidity patients with polypharmacy,the rate of polypharmacy reached 70.8%.The average number of medications taken per day was(8.6±3.2),minimum of 5 pills and a maximum of 72.5 pills,the incidence of adverse drug reactions was 29%.This study found that age,disease type and medication compliance were the influencing factors of polypharmacy for elderly multimorbidity at home.Conclusion The elderly comorbid patients at home are the high-risk group of multiple drug use,it is of great significance to manage multiple medication for elderly comorbid patients at home according to the influencing factors.

关 键 词：多重用药 居家老年人 共病 用药依从性 

分 类 号：R592[医药卫生—老年医学]